Trulicity (Dulaglutide)

Buy Trulicity from a Canadian Pharmacy online in the USA

Trulicity (Dulaglutide)

Dulaglutide


Product information

Trulicity (dulaglutide) for diabetes - available online from Canada! Trulicity is a once-weekly injection for adults with type 2 diabetes. It helps regulate blood sugar by mimicking the GLP-1 hormone. It's used alone or with other diabetes medications but not for type 1 diabetes. Common side effects include nausea and diarrhea. Not for pregnant or breastfeeding women.

In stock and ready to ship.

Prescription Required • Product of Canada • Shipping from Canada

Product options

Product strength & quantity

Brand Name

Product strength & quantity

Brand Name

SAVE on TRULICITY ordering online from Canada! (USA Prescription Required)


TRULICITY (Dulaglutide) - Canada Product Information



A video of Canadian Trulicity may be seen here


Trulicity is a medication used to help manage type 2 diabetes. It works by helping your body maintain proper blood sugar levels. It comes as an injection in a prefilled pen and is used once a week.


HOW DOES TRULICITY WORK?

Trulicity mimics a hormone in your body called GLP-1, which helps regulate blood sugar levels by increasing insulin secretion, slowing down the digestion process, and reducing the amount of sugar released by your liver.


WHO CAN USE TRULICITY?

Trulicity is suitable for adults with type 2 diabetes. It's typically prescribed when diet and exercise alone aren't enough to control blood sugar levels. It can be used alone or in combination with other diabetes medications, including metformin, sulfonylureas, SGLT2 inhibitors, or insulin.


WHO SHOULD NOT USE TRULICITY

  • People with type 1 diabetes or diabetic ketoacidosis.
  • Individuals with a history of severe allergic reactions to dulaglutide or any of the ingredients in Trulicity.
  • Those with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.
  • Pregnant or breastfeeding women.

  • HOW DO I TAKE TRULICITY

  • Inject Trulicity under the skin (subcutaneously) in the abdomen, thigh, or upper arm once a week, at any time of the day, with or without food.
  • If you miss a dose and there are at least 3 days (72 hours) before your next scheduled dose, take it as soon as possible. If less than 3 days remain, skip the missed dose and continue with your regular schedule.
  • Do not mix Trulicity with insulin in the same injection.

  • POSSIBLE SIDE EFFECTS


    Common side effects include:

  • Nausea, vomiting, diarrhea, and abdominal pain.
  • Reduced appetite and indigestion.
  • Injection site reactions such as redness or pain.
  • Possible increase in heart rate.

  • Serious but less common side effects:

  • Severe allergic reactions like swelling of the face, lips, tongue, or throat.
  • Pancreatitis (severe abdominal pain that doesn't go away).
  • Changes in kidney function, especially if you experience severe vomiting or diarrhea.
  • Thyroid tumors, including medullary thyroid cancer.

  • WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING TRULICITY?

    Inform your doctor if you:

  • Have or have had pancreatitis or kidney problems.
  • Have a history of diabetic retinopathy.
  • Are pregnant, planning to become pregnant, or breastfeeding.

  • STORAGE

  • Keep Trulicity pens in the refrigerator but do not freeze them.
  • If needed, you can store Trulicity pens at room temperature for up to 14 days.
  • Keep the pens in their original packaging to protect them from light.

  • SUPPLIED

    Trulicity from Canada is supplied in two strengths: 0.75 and 1.5 mg single use pens. Trulicity is dispensed in a carton of four single use pens (generally a 28 day supply dependant on dosage).

    OVERDOSE

    If you think you have used too much Trulicity, contact your doctor or local poison control center immediately. Symptoms of overdose might include severe nausea, vomiting, or low blood sugar.


    For any additional questions or concerns about Trulicity, talk to your healthcare provider.



    Reference: Trulicity Canada product monograph



    Product Video: Trulicity - Buying from Canada



    Off-Label Uses of Trulicity: Exploring Potential Benefits Beyond Diabetes Management


    Trulicity (dulaglutide) is a GLP-1 receptor agonist primarily prescribed for the management of type 2 diabetes. Its effectiveness in regulating blood sugar levels and promoting weight loss has led to interest in exploring its off-label uses. While off-label use refers to the prescription of a drug for conditions not approved by regulatory agencies, it's crucial to approach such practices with caution and under medical supervision.


    Weight Management

    One of the most prominent off-label uses of Trulicity is for weight management in non-diabetic individuals. Trulicity's mechanism of action includes slowing gastric emptying and reducing appetite, which can result in significant weight loss. Clinical studies have shown that Trulicity can help overweight or obese individuals achieve and maintain weight loss, making it a potential option for those struggling with obesity-related health issues.


    Polycystic Ovary Syndrome (PCOS)

    PCOS is a common endocrine disorder in women of reproductive age, often associated with insulin resistance and obesity. Trulicity's ability to improve insulin sensitivity and aid in weight loss has led some healthcare providers to consider its use in managing PCOS symptoms. Early research indicates that GLP-1 receptor agonists like Trulicity may help regulate menstrual cycles, improve ovulation, and reduce androgen levels in women with PCOS.


    Cardiovascular Health

    Beyond diabetes management, Trulicity has shown promise in improving cardiovascular health. It has been found to lower blood pressure, reduce LDL cholesterol levels, and improve endothelial function. Some studies suggest that Trulicity may benefit patients with cardiovascular conditions, even in the absence of diabetes. Its cardioprotective effects are attributed to weight loss, improved glycemic control, and direct effects on the cardiovascular system.

    Non-Alcoholic Fatty Liver Disease (NAFLD)

    NAFLD is a growing concern linked to obesity and insulin resistance. Preliminary studies indicate that Trulicity may help reduce liver fat and inflammation in patients with NAFLD. By improving insulin sensitivity and promoting weight loss, Trulicity could potentially serve as a therapeutic option for managing this liver condition.


    While the off-label use of Trulicity shows promise in various health conditions, it is essential to consult healthcare professionals before considering such treatments. Rigorous clinical trials are needed to confirm these benefits and ensure the safety and efficacy of Trulicity for off-label applications.